Skip to main content
Top
Published in: BMC Infectious Diseases 1/2016

Open Access 01-12-2016 | Research article

Gaining and sustaining schistosomiasis control: study protocol and baseline data prior to different treatment strategies in five African countries

Authors: Amara E. Ezeamama, Chun-La He, Ye Shen, Xiao-Ping Yin, Sue C. Binder, Carl H. Campbell Jr., Stephen Rathbun, Christopher C. Whalen, Eliézer K. N’Goran, Jürg Utzinger, Annette Olsen, Pascal Magnussen, Safari Kinung’hi, Alan Fenwick, Anna Phillips, Josefo Ferro, Diana M. S. Karanja, Pauline N. M. Mwinzi, Susan Montgomery, W. Evan Secor, Amina Hamidou, Amadou Garba, Charles H. King, Daniel G. Colley

Published in: BMC Infectious Diseases | Issue 1/2016

Login to get access

Abstract

Background

The Schistosomiasis Consortium for Operational Research and Evaluation (SCORE) was established in 2008 to answer strategic questions about schistosomiasis control. For programme managers, a high-priority question is: what are the most cost-effective strategies for delivering preventive chemotherapy (PCT) with praziquantel (PZQ)? This paper describes the process SCORE used to transform this question into a harmonized research protocol, the study design for answering this question, the village eligibility assessments and data resulting from the first year of the study.

Methods

Beginning in 2009, SCORE held a series of meetings to specify empirical questions and design studies related to different schedules of PCT for schistosomiasis control in communities with high (gaining control studies) and moderate (sustaining control studies) prevalence of Schistosoma infection among school-aged children. Seven studies are currently being implemented in five African countries. During the first year, villages were screened for eligibility, and data were collected on prevalence and intensity of infection prior to randomisation and the implementation of different schemes of PZQ intervention strategies.

Results

These studies of different treatment schedules with PZQ will provide the most comprehensive data thus far on the optimal frequency and continuity of PCT for schistosomiasis infection and morbidity control.

Conclusions

We expect that the study outcomes will provide data for decision-making for country programme managers and a rich resource of information to the schistosomiasis research community.

Trial registration

The trials are registered at International Standard Randomised Controlled Trial registry (identifiers: ISRCTN99401114, ISRCTN14849830, ISRCTN16755535, ISRCTN14117624, ISRCTN95819193 and ISRCTN32045736).
Literature
1.
go back to reference Colley DG. Morbidity control of schistosomiasis by mass drug administration: How can we do it best and what will it take to move on to elimination? Trop Med Health. 2014;42(2 Suppl):25–32.CrossRefPubMedPubMedCentral Colley DG. Morbidity control of schistosomiasis by mass drug administration: How can we do it best and what will it take to move on to elimination? Trop Med Health. 2014;42(2 Suppl):25–32.CrossRefPubMedPubMedCentral
2.
go back to reference Coulibaly JT, Knopp S, N’Guessan NA, Silué KD, Fürst T, Lohourignon LK, et al. Accuracy of urine circulating cathodic antigen (CCA) test for Schistosoma mansoni diagnosis in different settings of Côte d’Ivoire. PLoS Negl Trop Dis. 2011;5(11):e1384.CrossRefPubMedPubMedCentral Coulibaly JT, Knopp S, N’Guessan NA, Silué KD, Fürst T, Lohourignon LK, et al. Accuracy of urine circulating cathodic antigen (CCA) test for Schistosoma mansoni diagnosis in different settings of Côte d’Ivoire. PLoS Negl Trop Dis. 2011;5(11):e1384.CrossRefPubMedPubMedCentral
3.
go back to reference Colley DG, Binder S, Campbell C, King CH, Tchuem Tchuenté LA, N’Goran EK, et al. A five-country evaluation of a point-of-care circulating cathodic antigen urine assay for the prevalence of Schistosoma mansoni. Am J Trop Med Hyg. 2013;88(3):426–32.CrossRefPubMedPubMedCentral Colley DG, Binder S, Campbell C, King CH, Tchuem Tchuenté LA, N’Goran EK, et al. A five-country evaluation of a point-of-care circulating cathodic antigen urine assay for the prevalence of Schistosoma mansoni. Am J Trop Med Hyg. 2013;88(3):426–32.CrossRefPubMedPubMedCentral
4.
go back to reference Stothard JR, Stanton MC, Bustinduy AL, Sousa-Figueiredo JC, Van Dam GJ, Betson M, et al. Diagnostics for schistosomiasis in Africa and Arabia: a review of present options in control and future needs for elimination. Parasitology. 2014;141(14):1947–61.CrossRefPubMed Stothard JR, Stanton MC, Bustinduy AL, Sousa-Figueiredo JC, Van Dam GJ, Betson M, et al. Diagnostics for schistosomiasis in Africa and Arabia: a review of present options in control and future needs for elimination. Parasitology. 2014;141(14):1947–61.CrossRefPubMed
5.
go back to reference Knopp S, Corstjens PL, Koukounari A, Cercamondi CI, Ame SM, Ali SM, et al. Sensitivity and specificity of a urine circulating anodic antigen test for the diagnosis of Schistosoma haematobium in low endemic settings. PLoS Negl Trop Dis. 2015;9(5):e0003752.CrossRefPubMedPubMedCentral Knopp S, Corstjens PL, Koukounari A, Cercamondi CI, Ame SM, Ali SM, et al. Sensitivity and specificity of a urine circulating anodic antigen test for the diagnosis of Schistosoma haematobium in low endemic settings. PLoS Negl Trop Dis. 2015;9(5):e0003752.CrossRefPubMedPubMedCentral
6.
go back to reference Glenn TC, Lance SL, McKee AM, Webster BL, Emery AM, Zerlotini A, et al. Significant variance in genetic diversity among populations of Schistosoma haematobium detected using microsatellite DNA loci from a genome-wide database. Parasit Vectors. 2013;6(1):300.CrossRefPubMedPubMedCentral Glenn TC, Lance SL, McKee AM, Webster BL, Emery AM, Zerlotini A, et al. Significant variance in genetic diversity among populations of Schistosoma haematobium detected using microsatellite DNA loci from a genome-wide database. Parasit Vectors. 2013;6(1):300.CrossRefPubMedPubMedCentral
8.
go back to reference Knopp S, Mohammed KA, Ali SM, Khamis IS, Ame SM, Albonico M, et al. Study and implementation of urogenital schistosomiasis elimination in Zanzibar (Unguja and Pemba islands) using an integrated multidisciplinary approach. BMC Public Health. 2012;12:930.CrossRefPubMedPubMedCentral Knopp S, Mohammed KA, Ali SM, Khamis IS, Ame SM, Albonico M, et al. Study and implementation of urogenital schistosomiasis elimination in Zanzibar (Unguja and Pemba islands) using an integrated multidisciplinary approach. BMC Public Health. 2012;12:930.CrossRefPubMedPubMedCentral
9.
go back to reference Knopp S, Becker SL, Ingram KJ, Keiser J, Utzinger J. Diagnosis and treatment of schistosomiasis in children in the era of intensified control. Expert Rev Anti Infect Ther. 2013;11(11):1237–58.CrossRefPubMed Knopp S, Becker SL, Ingram KJ, Keiser J, Utzinger J. Diagnosis and treatment of schistosomiasis in children in the era of intensified control. Expert Rev Anti Infect Ther. 2013;11(11):1237–58.CrossRefPubMed
10.
go back to reference Assaré RK, Knopp S, N’Guessan NA, Yapi A, Tian-Bi YN, Yao PK, et al. Sustaining control of schistosomiasis mansoni in moderate endemicity areas in western Côte d’Ivoire: a SCORE study protocol. BMC Public Health. 2014;14:1290.CrossRefPubMedPubMedCentral Assaré RK, Knopp S, N’Guessan NA, Yapi A, Tian-Bi YN, Yao PK, et al. Sustaining control of schistosomiasis mansoni in moderate endemicity areas in western Côte d’Ivoire: a SCORE study protocol. BMC Public Health. 2014;14:1290.CrossRefPubMedPubMedCentral
11.
go back to reference Hagan P, Chandiwana S, Ndhlovu P, Woolhouse MEJ, Dessein A. The epidemiology, immunology and morbidity of Schistosoma haematobium infections in diverse communities in Zimbabwe. I. The study design. Trop Geogr Med. 1994;46(4 Spec No):227–32.PubMed Hagan P, Chandiwana S, Ndhlovu P, Woolhouse MEJ, Dessein A. The epidemiology, immunology and morbidity of Schistosoma haematobium infections in diverse communities in Zimbabwe. I. The study design. Trop Geogr Med. 1994;46(4 Spec No):227–32.PubMed
12.
go back to reference Vennervald BJ, Ouma JH, Butterworth AE. Morbidity in schistosomiasis: assessment, mechanisms and control. Parasitol Today. 1998;14(10):385–90.CrossRefPubMed Vennervald BJ, Ouma JH, Butterworth AE. Morbidity in schistosomiasis: assessment, mechanisms and control. Parasitol Today. 1998;14(10):385–90.CrossRefPubMed
13.
go back to reference Woolhouse MEJ, Mutapi F, Ndhlovu PD, Chandiwana SK, Hagan P. Exposure, infection and immune responses to Schistosoma haematobium in young children. Parasitology. 2000;120(Pt 1):37–44.CrossRefPubMed Woolhouse MEJ, Mutapi F, Ndhlovu PD, Chandiwana SK, Hagan P. Exposure, infection and immune responses to Schistosoma haematobium in young children. Parasitology. 2000;120(Pt 1):37–44.CrossRefPubMed
14.
go back to reference Kabatereine NB, Kemijumbi J, Ouma JH, Kariuki HC, Richter J, Kadzo H, et al. Epidemiology and morbidity of Schistosoma mansoni infection in a fishing community along Lake Albert in Uganda. Trans R Soc Trop Med Hyg. 2004;98(12):711–8.CrossRefPubMed Kabatereine NB, Kemijumbi J, Ouma JH, Kariuki HC, Richter J, Kadzo H, et al. Epidemiology and morbidity of Schistosoma mansoni infection in a fishing community along Lake Albert in Uganda. Trans R Soc Trop Med Hyg. 2004;98(12):711–8.CrossRefPubMed
15.
go back to reference Salam RA, Maredia H, Das JK, Lassi ZS, Bhutta ZA. Community-based interventions for the prevention and control of helmintic neglected tropical diseases. Infect Dis Poverty. 2014;3:23.CrossRefPubMedPubMedCentral Salam RA, Maredia H, Das JK, Lassi ZS, Bhutta ZA. Community-based interventions for the prevention and control of helmintic neglected tropical diseases. Infect Dis Poverty. 2014;3:23.CrossRefPubMedPubMedCentral
16.
go back to reference King CH, Dickman K, Tisch DJ. Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet. 2005;365(9470):1561–9.CrossRefPubMed King CH, Dickman K, Tisch DJ. Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet. 2005;365(9470):1561–9.CrossRefPubMed
17.
go back to reference Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis. 2006;6(7):411–25.CrossRefPubMed Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis. 2006;6(7):411–25.CrossRefPubMed
19.
go back to reference Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2197–223.CrossRefPubMed Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2197–223.CrossRefPubMed
20.
go back to reference WHO. Preventive chemotherapy in human helminthiasis: coordinated use of anthelminthic drugs in control interventions: a manual for health professionals and programme managers. Geneva: World Health Organization; 2006. In. World Health Organization; 2006. WHO. Preventive chemotherapy in human helminthiasis: coordinated use of anthelminthic drugs in control interventions: a manual for health professionals and programme managers. Geneva: World Health Organization; 2006. In. World Health Organization; 2006.
21.
go back to reference Brady MA, Hooper PJ, Ottesen EA. Projected benefits from integrating NTD programs in sub-Saharan Africa. Trends Parasitol. 2006;22(7):285–91.CrossRefPubMed Brady MA, Hooper PJ, Ottesen EA. Projected benefits from integrating NTD programs in sub-Saharan Africa. Trends Parasitol. 2006;22(7):285–91.CrossRefPubMed
22.
go back to reference Toure S, Zhang Y, Bosque-Oliva E, Ky C, Ouedraogo A, Koukounari A, et al. Two-year impact of single praziquantel treatment on infection in the national control programme on schistosomiasis in Burkina Faso. Bull World Health Organ. 2008;86(10):780–7.CrossRefPubMedPubMedCentral Toure S, Zhang Y, Bosque-Oliva E, Ky C, Ouedraogo A, Koukounari A, et al. Two-year impact of single praziquantel treatment on infection in the national control programme on schistosomiasis in Burkina Faso. Bull World Health Organ. 2008;86(10):780–7.CrossRefPubMedPubMedCentral
23.
go back to reference Kabatereine NB, Malecela M, Lado M, Zaramba S, Amiel O, Kolaczinski JH. How to (or not to) integrate vertical programmes for the control of major neglected tropical diseases in sub-Saharan Africa. PLoS Negl Trop Dis. 2010;4(6):e755.CrossRefPubMedPubMedCentral Kabatereine NB, Malecela M, Lado M, Zaramba S, Amiel O, Kolaczinski JH. How to (or not to) integrate vertical programmes for the control of major neglected tropical diseases in sub-Saharan Africa. PLoS Negl Trop Dis. 2010;4(6):e755.CrossRefPubMedPubMedCentral
24.
go back to reference King CH, Olbrych SK, Soon M, Singer ME, Carter J, Colley DG. Utility of repeated praziquantel dosing in the treatment of schistosomiasis in high-risk communities in Africa: a systematic review. PLoS Negl Trop Dis. 2011;5(9):e1321.CrossRefPubMedPubMedCentral King CH, Olbrych SK, Soon M, Singer ME, Carter J, Colley DG. Utility of repeated praziquantel dosing in the treatment of schistosomiasis in high-risk communities in Africa: a systematic review. PLoS Negl Trop Dis. 2011;5(9):e1321.CrossRefPubMedPubMedCentral
25.
go back to reference Hanson C, Weaver A, Zoerhoff KL, Kabore A, Linehan M, Doherty A, et al. Integrated implementation of programs targeting neglected tropical diseases through preventive chemotherapy: identifying best practices to roll out programs at national scale. Am J Trop Med Hyg. 2012;86(3):508–13.CrossRefPubMedPubMedCentral Hanson C, Weaver A, Zoerhoff KL, Kabore A, Linehan M, Doherty A, et al. Integrated implementation of programs targeting neglected tropical diseases through preventive chemotherapy: identifying best practices to roll out programs at national scale. Am J Trop Med Hyg. 2012;86(3):508–13.CrossRefPubMedPubMedCentral
26.
go back to reference Assaré RK, Hürlimann E, Ouattara M, N’Guessan NA, Tian-Bi YN, Yapi A, et al. Sustaining the control of schistosoma mansoni in Western Côte d’Ivoire: baseline findings before the implementation of a randomized trial. Am J Trop Med Hyg. 2015. Assaré RK, Hürlimann E, Ouattara M, N’Guessan NA, Tian-Bi YN, Yapi A, et al. Sustaining the control of schistosoma mansoni in Western Côte d’Ivoire: baseline findings before the implementation of a randomized trial. Am J Trop Med Hyg. 2015.
27.
go back to reference Katz N, Chaves A, Pellegrino J. A simple device for quantitative stool thick-smear technique in schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo. 1972;14(6):397–400.PubMed Katz N, Chaves A, Pellegrino J. A simple device for quantitative stool thick-smear technique in schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo. 1972;14(6):397–400.PubMed
28.
go back to reference Peters PAS, Kazura JW. Update on diagnostic methods for schistosomiasis. In: Mahmoud AA, editor. Balliere’s clinical tropical medicine and communicable diseases, schistosomiasis. Volume. London: Bailliere Tindall; 1987: 419–433. Peters PAS, Kazura JW. Update on diagnostic methods for schistosomiasis. In: Mahmoud AA, editor. Balliere’s clinical tropical medicine and communicable diseases, schistosomiasis. Volume. London: Bailliere Tindall; 1987: 419–433.
29.
go back to reference WHO. Guidelines for the evaluation of soil-transmitted helminthiasis and schistosomiasis at community level: a guide for managers of control programmes. Geneva: World Health Organization; 1998. p. 45. WHO. Guidelines for the evaluation of soil-transmitted helminthiasis and schistosomiasis at community level: a guide for managers of control programmes. Geneva: World Health Organization; 1998. p. 45.
30.
go back to reference King CH, Bertsch D. Meta-analysis of urine heme dipstick diagnosis of Schistosoma haematobium infection, including low-prevalence and previously-treated populations. PLoS Negl Trop Dis. 2013;7(9):e2431.CrossRefPubMedPubMedCentral King CH, Bertsch D. Meta-analysis of urine heme dipstick diagnosis of Schistosoma haematobium infection, including low-prevalence and previously-treated populations. PLoS Negl Trop Dis. 2013;7(9):e2431.CrossRefPubMedPubMedCentral
31.
go back to reference Olsen A, Kinung’hi S, Magnussen P. Schistosoma mansoni infection along the coast of Lake Victoria in Mwanza region, Tanzania. Am J Trop Med Hyg. 2015;92(6):1240–4.CrossRefPubMed Olsen A, Kinung’hi S, Magnussen P. Schistosoma mansoni infection along the coast of Lake Victoria in Mwanza region, Tanzania. Am J Trop Med Hyg. 2015;92(6):1240–4.CrossRefPubMed
32.
go back to reference Organization WH. Schistosomiasis: number of people treated worldwide in 2013. Wkly Epidemiol Rec. 2015;90(5):25–32. Organization WH. Schistosomiasis: number of people treated worldwide in 2013. Wkly Epidemiol Rec. 2015;90(5):25–32.
33.
go back to reference Wang X, Gurarie D, Mungai PL, Muchiri EM, Kitron U, King CH. Projecting the long-term impact of school- or community-based mass-treatment interventions for control of Schistosoma infection. PLoS Negl Trop Dis. 2012;6(11):e1903.CrossRefPubMedPubMedCentral Wang X, Gurarie D, Mungai PL, Muchiri EM, Kitron U, King CH. Projecting the long-term impact of school- or community-based mass-treatment interventions for control of Schistosoma infection. PLoS Negl Trop Dis. 2012;6(11):e1903.CrossRefPubMedPubMedCentral
34.
go back to reference Gurarie D, King CH. Population biology of Schistosoma mating, aggregation, and transmission breakpoints: more reliable model analysis for the end-game in communities at risk. PLoS One. 2014;9(12):e115875.CrossRefPubMedPubMedCentral Gurarie D, King CH. Population biology of Schistosoma mating, aggregation, and transmission breakpoints: more reliable model analysis for the end-game in communities at risk. PLoS One. 2014;9(12):e115875.CrossRefPubMedPubMedCentral
36.
go back to reference Olliaro PL, Vaillant M, Diawara A, Coulibaly JT, Garba A, Keiser J, et al. Toward measuring schistosoma response to praziquantel treatment with appropriate descriptors of egg excretion. PLoS Negl Trop Dis. 2015;9(6):e0003821.CrossRefPubMedPubMedCentral Olliaro PL, Vaillant M, Diawara A, Coulibaly JT, Garba A, Keiser J, et al. Toward measuring schistosoma response to praziquantel treatment with appropriate descriptors of egg excretion. PLoS Negl Trop Dis. 2015;9(6):e0003821.CrossRefPubMedPubMedCentral
37.
go back to reference Aagaard-Hansen J, Mwanga JR, Bruun B. Social science perspectives on schistosomiasis control in Africa: past trends and future directions. Parasitology. 2009;136(13):1747–58.CrossRefPubMed Aagaard-Hansen J, Mwanga JR, Bruun B. Social science perspectives on schistosomiasis control in Africa: past trends and future directions. Parasitology. 2009;136(13):1747–58.CrossRefPubMed
38.
go back to reference Liese B, Rosenberg M, Schratz A. Programmes, partnerships, and governance for elimination and control of neglected tropical diseases. Lancet. 2010;375(9708):67–76.CrossRefPubMed Liese B, Rosenberg M, Schratz A. Programmes, partnerships, and governance for elimination and control of neglected tropical diseases. Lancet. 2010;375(9708):67–76.CrossRefPubMed
39.
go back to reference Utzinger J, N’Goran EK, Caffrey CR, Keiser J. From innovation to application: social-ecological context, diagnostics, drugs and integrated control of schistosomiasis. Acta Trop. 2011;120 Suppl 1:S121–37.CrossRefPubMed Utzinger J, N’Goran EK, Caffrey CR, Keiser J. From innovation to application: social-ecological context, diagnostics, drugs and integrated control of schistosomiasis. Acta Trop. 2011;120 Suppl 1:S121–37.CrossRefPubMed
40.
go back to reference Freeman MC, Ogden S, Jacobson J, Abbott D, Addiss DG, Amnie AG, et al. Integration of water, sanitation, and hygiene for the prevention and control of neglected tropical diseases: a rationale for inter-sectoral collaboration. PLoS Negl Trop Dis. 2013;7(9):e2439.CrossRefPubMedPubMedCentral Freeman MC, Ogden S, Jacobson J, Abbott D, Addiss DG, Amnie AG, et al. Integration of water, sanitation, and hygiene for the prevention and control of neglected tropical diseases: a rationale for inter-sectoral collaboration. PLoS Negl Trop Dis. 2013;7(9):e2439.CrossRefPubMedPubMedCentral
41.
go back to reference Rollinson D, Knopp S, Levitz S, Stothard JR, Tchuem Tchuenté LA, Garba A, et al. Time to set the agenda for schistosomiasis elimination. Acta Trop. 2013;128(2):423–40.CrossRefPubMed Rollinson D, Knopp S, Levitz S, Stothard JR, Tchuem Tchuenté LA, Garba A, et al. Time to set the agenda for schistosomiasis elimination. Acta Trop. 2013;128(2):423–40.CrossRefPubMed
42.
go back to reference Spear RC. Commentary by Spear, R. on “Integration of water, sanitation, and hygiene for the prevention and control of neglected tropical diseases: a rationale for inter-sectoral collaboration:” can the control of NTDs profit from a good WASH? PLoS Negl Trop Dis. 2013;7(9):e2473.CrossRefPubMedPubMedCentral Spear RC. Commentary by Spear, R. on “Integration of water, sanitation, and hygiene for the prevention and control of neglected tropical diseases: a rationale for inter-sectoral collaboration:” can the control of NTDs profit from a good WASH? PLoS Negl Trop Dis. 2013;7(9):e2473.CrossRefPubMedPubMedCentral
43.
go back to reference Grimes JE, Croll D, Harrison WE, Utzinger J, Freeman MC, Templeton MR. The relationship between water, sanitation and schistosomiasis: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2014;8(12):e3296.CrossRefPubMedPubMedCentral Grimes JE, Croll D, Harrison WE, Utzinger J, Freeman MC, Templeton MR. The relationship between water, sanitation and schistosomiasis: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2014;8(12):e3296.CrossRefPubMedPubMedCentral
44.
go back to reference Grimes JE, Croll D, Harrison WE, Utzinger J, Freeman MC, Templeton MR. The roles of water, sanitation and hygiene in reducing schistosomiasis: a review. Parasit Vectors. 2015;8:156.CrossRefPubMedPubMedCentral Grimes JE, Croll D, Harrison WE, Utzinger J, Freeman MC, Templeton MR. The roles of water, sanitation and hygiene in reducing schistosomiasis: a review. Parasit Vectors. 2015;8:156.CrossRefPubMedPubMedCentral
Metadata
Title
Gaining and sustaining schistosomiasis control: study protocol and baseline data prior to different treatment strategies in five African countries
Authors
Amara E. Ezeamama
Chun-La He
Ye Shen
Xiao-Ping Yin
Sue C. Binder
Carl H. Campbell Jr.
Stephen Rathbun
Christopher C. Whalen
Eliézer K. N’Goran
Jürg Utzinger
Annette Olsen
Pascal Magnussen
Safari Kinung’hi
Alan Fenwick
Anna Phillips
Josefo Ferro
Diana M. S. Karanja
Pauline N. M. Mwinzi
Susan Montgomery
W. Evan Secor
Amina Hamidou
Amadou Garba
Charles H. King
Daniel G. Colley
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2016
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-016-1575-2

Other articles of this Issue 1/2016

BMC Infectious Diseases 1/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine